| Code | Description | Claims | Beneficiaries | Total Paid |
| H0040 |
Assertive community treatment program, per diem |
2,614 |
2,599 |
$4.83M |
| H0020 |
Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) |
114,277 |
8,254 |
$3.43M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,375 |
9,983 |
$2.16M |
| G2067 |
Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) |
10,025 |
3,914 |
$2.06M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,276 |
6,969 |
$1.70M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,984 |
6,966 |
$1.32M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,214 |
4,784 |
$841K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,848 |
4,236 |
$822K |
| 80053 |
Comprehensive metabolic panel |
12,370 |
11,770 |
$720K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,346 |
2,272 |
$711K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,059 |
1,543 |
$628K |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
5,285 |
4,064 |
$610K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,850 |
1,815 |
$531K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,775 |
2,556 |
$521K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,963 |
2,441 |
$460K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,529 |
5,270 |
$408K |
| 97597 |
|
1,112 |
526 |
$337K |
| 99215 |
Prolong outpt/office vis |
1,105 |
1,080 |
$257K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
731 |
722 |
$186K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
699 |
668 |
$171K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,732 |
5,536 |
$157K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,796 |
1,785 |
$133K |
| G0397 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes |
775 |
674 |
$117K |
| 36415 |
Collection of venous blood by venipuncture |
5,958 |
5,665 |
$115K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,853 |
1,830 |
$105K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,102 |
1,460 |
$97K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,274 |
2,207 |
$95K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
905 |
885 |
$75K |
| 82803 |
|
2,861 |
2,773 |
$58K |
| H0004 |
Behavioral health counseling and therapy, per 15 minutes |
1,024 |
771 |
$57K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,176 |
1,161 |
$54K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,395 |
1,363 |
$52K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
163 |
163 |
$38K |
| 86850 |
|
946 |
928 |
$36K |
| 86480 |
|
539 |
537 |
$33K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,843 |
1,820 |
$33K |
| 80061 |
Lipid panel |
3,033 |
3,010 |
$32K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,417 |
480 |
$31K |
| 86901 |
|
946 |
928 |
$27K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,784 |
4,625 |
$24K |
| 76830 |
Ultrasound, transvaginal |
465 |
460 |
$24K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
95 |
95 |
$24K |
| H0050 |
Alcohol and/or drug services, brief intervention, per 15 minutes |
488 |
388 |
$24K |
| 97161 |
|
191 |
191 |
$23K |
| 90834 |
Psychotherapy, 45 minutes with patient |
162 |
68 |
$20K |
| G0378 |
Hospital observation service, per hour |
13 |
13 |
$18K |
| 71046 |
Radiologic examination, chest; 2 views |
2,955 |
2,908 |
$18K |
| 86900 |
|
946 |
928 |
$17K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,249 |
2,198 |
$17K |
| H0034 |
Medication training and support, per 15 minutes |
746 |
585 |
$17K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
12 |
12 |
$15K |
| 0012A |
|
363 |
362 |
$14K |
| 83880 |
|
669 |
630 |
$14K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,296 |
2,286 |
$13K |
| 85610 |
|
3,484 |
3,350 |
$13K |
| 0011A |
|
374 |
373 |
$12K |
| 88142 |
|
267 |
267 |
$12K |
| 81025 |
|
240 |
231 |
$11K |
| 90715 |
|
452 |
337 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,959 |
10,336 |
$10K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
70 |
68 |
$10K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
51 |
51 |
$8K |
| 87536 |
|
86 |
83 |
$8K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
27 |
27 |
$7K |
| 76641 |
|
189 |
165 |
$7K |
| 12001 |
|
12 |
12 |
$7K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,475 |
1,462 |
$7K |
| 86769 |
|
262 |
257 |
$7K |
| 96127 |
|
1,839 |
1,731 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
243 |
241 |
$6K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
12 |
12 |
$6K |
| J3490 |
Unclassified drugs |
485 |
420 |
$5K |
| 81001 |
|
5,467 |
5,273 |
$5K |
| 96368 |
|
194 |
189 |
$5K |
| 76376 |
|
1,154 |
1,138 |
$5K |
| 0064A |
|
112 |
112 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
53 |
53 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
30 |
27 |
$4K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
54 |
54 |
$4K |
| 97010 |
|
55 |
21 |
$4K |
| 99386 |
|
39 |
39 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,790 |
3,625 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
71 |
66 |
$3K |
| 29581 |
|
19 |
13 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,738 |
2,639 |
$3K |
| 73630 |
|
555 |
493 |
$3K |
| 97014 |
|
41 |
14 |
$2K |
| H0005 |
Alcohol and/or drug services; group counseling by a clinician |
32 |
13 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,933 |
1,859 |
$2K |
| 0031A |
|
63 |
63 |
$2K |
| 90654 |
|
88 |
88 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
53 |
53 |
$2K |
| 99442 |
|
13 |
13 |
$2K |
| 77065 |
Tomosynthesis, mammo |
26 |
26 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
1,129 |
1,082 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
166 |
163 |
$2K |
| 86592 |
|
605 |
603 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
379 |
378 |
$1K |
| 84484 |
|
1,704 |
1,636 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
585 |
577 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,969 |
2,808 |
$1K |
| 86361 |
|
41 |
40 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
640 |
378 |
$969.35 |
| 87088 |
|
968 |
948 |
$953.81 |
| 85730 |
|
2,019 |
1,941 |
$920.25 |
| 96367 |
|
15 |
15 |
$863.76 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
13 |
13 |
$816.58 |
| 90686 |
|
37 |
37 |
$792.05 |
| 73030 |
|
120 |
108 |
$763.06 |
| 80076 |
|
75 |
74 |
$712.24 |
| 99443 |
|
12 |
12 |
$607.26 |
| 84439 |
|
178 |
176 |
$550.27 |
| 73130 |
|
250 |
238 |
$547.01 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
707 |
664 |
$536.31 |
| 73610 |
|
96 |
89 |
$520.05 |
| 83735 |
|
1,368 |
1,340 |
$496.39 |
| 83690 |
|
2,446 |
2,346 |
$460.10 |
| 80069 |
|
16 |
16 |
$424.54 |
| 81003 |
|
206 |
147 |
$400.08 |
| 72100 |
|
50 |
50 |
$390.21 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
90 |
90 |
$338.83 |
| 82043 |
|
109 |
108 |
$298.68 |
| 80320 |
|
1,274 |
1,209 |
$284.35 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
636 |
624 |
$265.85 |
| 80329 |
|
288 |
281 |
$253.85 |
| 84702 |
|
209 |
195 |
$237.50 |
| 82550 |
|
882 |
841 |
$219.06 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
703 |
688 |
$194.35 |
| 82607 |
|
38 |
38 |
$154.18 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
129 |
121 |
$145.64 |
| 88399 |
|
14 |
14 |
$126.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
828 |
800 |
$124.99 |
| 96376 |
|
41 |
40 |
$106.39 |
| 73562 |
|
39 |
37 |
$102.53 |
| 86803 |
|
15 |
15 |
$102.41 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
431 |
418 |
$87.58 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
130 |
130 |
$87.34 |
| D0120 |
Periodic oral evaluation - established patient |
13 |
13 |
$83.52 |
| 85652 |
|
112 |
110 |
$77.95 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
649 |
594 |
$71.36 |
| 81002 |
|
169 |
166 |
$67.93 |
| 87340 |
|
43 |
42 |
$65.06 |
| J2704 |
Injection, propofol, 10 mg |
42 |
42 |
$54.57 |
| 86706 |
|
33 |
32 |
$40.20 |
| J2060 |
Injection, lorazepam, 2 mg |
92 |
90 |
$36.21 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
58 |
55 |
$36.00 |
| 86141 |
|
82 |
81 |
$30.75 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
43 |
39 |
$24.75 |
| J1630 |
Injection, haloperidol, up to 5 mg |
40 |
38 |
$16.07 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
74 |
73 |
$8.83 |
| 87040 |
|
156 |
155 |
$8.15 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
143 |
139 |
$4.06 |
| J7050 |
Infusion, normal saline solution, 250 cc |
15 |
15 |
$3.50 |
| 81015 |
|
100 |
100 |
$2.02 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
19 |
16 |
$1.92 |
| 91301 |
|
356 |
339 |
$1.80 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
53 |
49 |
$1.05 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
12 |
12 |
$0.76 |
| 99080 |
|
2,271 |
419 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
15 |
14 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14 |
14 |
$0.00 |
| 87070 |
|
12 |
12 |
$0.00 |
| 82150 |
|
13 |
13 |
$0.00 |
| 85379 |
|
12 |
12 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
57 |
54 |
$0.00 |
| 87081 |
|
16 |
16 |
$0.00 |